AQEMIA

AQEMIA is a next-generation pharmatech company utilizing generative AI and deep physics to accelerate drug discovery. Its proprietary platform designs innovative drug candidates for various critical diseases, boasting several successful projects in its internal pipeline and collaborations with pharmaceutical companies. The company's unique approach aims to significantly reshape the drug discovery landscape.

Funding Round: Series A

Funding Amount: €60M

Date: 30-Jan-2024

Investors: Wendel Growth, Bpifrance Large Venture, Eurazeo, Elaia

Markets: Healthtech, Life Sciences, AI

HQ: Paris, Île-de-France, France

Founded: 2019

Website: https://www.aqemia.com/

LinkedIn: https://www.linkedin.com/company/aqemia/

Twitter: https://twitter.com/aqemia

Instagram:

Facebook: